Skip to main content
. 2021 Aug 9;14:121. doi: 10.1186/s13045-021-01111-4

Table 2.

List of pre-clinical direct MYC inhibitors

Mechanism Type Compound References
Inhibitor of MYC/Max dimerization Small Molecule IIA6B17 [672]
10058-F4 [673]
10074-G5 [674]
JY-3-094 [675]
3jc48–3 [676]
MYCro1, MYCro2, MYCro3 [677]
MYCMI-6 [676]
KJ-Pyr-9 [678]
EN4 [679]
MYCi361 [680]
MYCi975 [681]
KI-MS2-008 [682]
(Poly)peptide OmoMYC [683]
FPPa-OmoMYC [684]
Max bHLHZ (OmoMYC) [685]
Mxd1 [686]
Monoclonal antibody [687]
H1 peptide [688]
Inhibitor of E-box binding Small Molecule JKY-2-169 [689]
(Poly)peptide OmoMYC [683]
Max bHLHZ [685]
Mxd1 [686]
ME47 [690]